Integra Lifesciences Holdings Earnings Preview: Can This Streak Continue?

Integra Lifesciences Holdings (NASDAQ:IART) will report earnings before markets open on Thursday, May 2nd. Integra LifeSciences Holdings develops, manufactures, and markets medical devices, implants, and biomaterials. The Company’s products are primarily used in the treatment of burns and skin defects, spinal and cranial disorders, orthopedics, and other surgical applications.

Here is your Cheat Sheet to Integra Lifesciences Holdings Earnings:

Earnings Expectations: Analysts expect earnings of $0.54 per share on revenues of $199.86 million. Currently, the company’s P/E ratio stands at 23.45.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.78 to a profit $0.69. For the current year, the average estimate is a profit of $2.89, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Integra Lifesciences Holdings has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 654.60 682.49 732.07 780.08 830.87
Diluted EPS ($) 0.96 1.74 2.17 0.95 1.44

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 203.52 196.18 210.17 210.08 214.43
Diluted EPS ($) 0.1599 0.23 0.30 0.46 0.4538

Past Performance:
Integra Lifesciences Holdings has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]